Mexiletine and persistent ophthalmic changes

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mexilitine is an anti-arrhythmic agent used to treat neuropathic pain. The drug has a low side-effect profile with gastritis as the predominant complaint. The following two cases suggest that mexilitine can potentially cause persistent ophthalmic changes and should be used with caution in chronic pain patients with preexisting ocular disease.

Cite

CITATION STYLE

APA

Leong, M. S., Isolani, F., & Gaeta, R. R. (2001). Mexiletine and persistent ophthalmic changes. Pain Medicine, 2(3), 228–229. https://doi.org/10.1046/j.1526-4637.2001.01027.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free